Cognizant Technology Solutions Corporation (CTSH) Cash Flow Statement

Net income held within a fairly narrow band of roughly $546M to $663M across the ten quarters, while operating cash flow ranged from about $262M to $1.2B, so the gap between the two is driven almost entirely by working capital timing rather than by changes in reported profitability. The pattern suggests that the most material signal is the cumulative relationship over several quarters rather than any single period. Investors should monitor whether the strong quarters reflect genuine collection improvement or the reversal of prior receivable build-ups, since the reported figures alone cannot distinguish between the two.

The alternating build and release pattern is consistent with receivables cycling through quarter-end, which is typical of a services business with large enterprise clients but still warrants close attention. The repeated reversals imply that cash generation is being shifted between periods rather than created or lost outright. Investors should watch whether the trailing working capital position is stabilizing, since persistent build-ups would indicate slower collections than the headline earnings suggest.

Averaging across the period, free cash flow margin sits in the mid-teens, which is respectable for an IT services company with modest capital needs, yet the quarterly dispersion is large enough to make run-rate estimates unreliable. Capital expenditure stayed low, at roughly 1.1% to 1.6% of revenue, so the swings are attributable to operating cash flow rather than investment intensity. This suggests that free cash flow quality depends heavily on working capital management, warranting further investigation into collection consistency.

The steady dividend outflow appears largely insulated from quarterly cash fluctuations, which suggests management treats it as a fixed commitment, while buybacks and acquisitions have tracked the cash swings more closely. Notable acquisition outflows in several quarters, including a reported $1.2B in 2024Q3 and $730M in 2026Q1, indicate that capital allocation has been lumpy and that investors may need to assess whether these deployments have produced returns commensurate with their cost.